En los confines helados del espacio, Saturno guarda un secreto fascinante que ha desconcertado a científicos y entusiastas del espacio por décadas: el misterioso hexágono en su polo norte. Se trata de un fenómeno geométrico único, así que exploremos s …
Los astrónomos no podían creer lo que descubrieron en Saturno Read More »
Telix Pharmaceuticals Limited announces that the first patient has been dosed in the Company’s Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen targeting radio-antibody drug conjugate therapy, TLX591.
Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences, announced during a Late-Breaking session of the American Heart Association meeting that abelacimab demonstrated a highly significant reduction in bleeding events across all primary and secondary endpoints versus a standard of care direct-oral anticoagulant.
A recent study from Hospital for Special Surgery and others has found a correlation between obesity and more severe disease flare symptoms that negatively affect quality of life in patients with early rheumatoid arthritis, a systemic, autoimmune, inflammatory disorder affecting multiple joints in the body.
Lexicon Pharmaceuticals, Inc. announced that a post hoc analysis of clinical data from the SCORED trial demonstrated that clinical benefit from INPEFA® use in heart failure and major adverse cardiovascular events related outcomes was observed as early as approximately three months in patients at high risk for cardiovascular events.
Ascletis Pharma Inc. announces late-breaking abstract poster presentation of interim results from Phase IIb expansion cohort of ASC22 for functional cure of chronic hepatitis B, and abstract poster presentation of Phase I study results of ASC41 for treatment of non-alcoholic steatohepatitis at The Liver Meeting® 2023 of the American Association for the Study of Liver
Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, presented first-in-human data from a Phase 1 trial investigating AB-1002 for the treatment of patients with congestive heart failure at this year’s American Heart Association Scientific Sessions, which are being held in Philadelphia, U.S., from November 11
Over the next two weeks, the FDA is set to decide on New Drug Applications from Pacira, CorMedix and Aldeyra and hold an advisory committee meeting for two overdue confirmatory trials from Acrotech.
FDA Action Alert: Pacira, CorMedix, Aldeyra and More Read More »
As Vertex and CRISPR Therapeutics await the monumental potential approval of exa-cel, bluebird bio, Iovance and Rocket Pharmaceuticals wait patiently in the wings.
Cell & Gene Therapy Space Gears Up for First CRISPR Approval Read More »
To protect the central nervous system, the blood-brain barrier bars entry to around 98% of molecules—but approaches like Roche’s trontinemab could spell new hope in Alzheimer’s and beyond.
Companies Devise New Ways to Smuggle Drugs Across the Blood-Brain Barrier Read More »
